• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

ketamine

psychedelic brain think thought hallucinogenic psychology
Favicon Fierce Biotech

FDA holds psychedelic hearing as historic approval looms

Many speakers urged the FDA to ensure that as many patients as possible can access psychedelics, while a few highlighted safety concerns.
Darren Incorvaia Sep 14, 2026 6:00pm
FDA

FDA dings Alar over ‘extremely concerning’ ketamine claims

Aug 31, 2026 3:46pm
A frame from SK Life Sciences Road to Reduction ad for Xcopri showing a car driving down a straight road under the drugs

SK Life Science Xcopri ad meets a roadblock with FDA letter

Nov 24, 2025 12:00pm
Man on white background

Canadian company hopes to take psychedelic therapy mainstream

Jan 24, 2023 6:25am
handshake

PharmaTher grows ketamine portfolio with on-body injector deal

May 27, 2022 8:25am
deal

Bexson expands on-body ketamine delivery work into mental health

May 3, 2022 11:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings